🔎 Trials Near Me

Home › Leukemia › Texas › Dallas

Leukemia clinical trials in Dallas, TX

8 studies for Leukemia are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

RecruitingPhase 1
  • Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT06001788

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

RecruitingPhase 3
  • Texas Oncology-Presbyterian Cancer Center, Dallas
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT07007312

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

RecruitingPhase 2
  • University of Texas, Southwestern, Dallas
Ages 7 to 25 · All sexes · Updated Aug 19, 2026 · NCT05082519

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

RecruitingObservational study
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
All ages · All sexes · Updated May 18, 2026 · NCT01790152

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

RecruitingPhase 2/3
  • University of Texas Southwestern Medical Center, Dallas
Ages 18 and older · All sexes · Updated Apr 30, 2026 · NCT04256317

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

RecruitingPhase 1/2
  • University of Texas(UT) Southwestern-Children's Medical Center, Dallas
Ages 12 to 95 · All sexes · Updated Apr 15, 2026 · NCT04329728

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

RecruitingPhase 1
  • UT Southwestern - Simmons Cancer Center, Dallas
Ages 18 and older · All sexes · Updated Mar 13, 2026 · NCT05735184

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Dallas
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

About Leukemia

Leukemia is cancer of the white blood cells. There are two types of Leukemias, acute and chronic. Learn about the differences and treatments available.

More about Leukemia on MedlinePlus

Leukemia trials in other cities

Other studies in Dallas

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.